Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Clinical trial NCT02992132 · TERMINATED
Trial details
- NCT number
- NCT02992132
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-01-25
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.